337 related articles for article (PubMed ID: 25496194)
41. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.
Monaco EA; Faraji AH; Berkowitz O; Parry PV; Hadelsberg U; Kano H; Niranjan A; Kondziolka D; Lunsford LD
Cancer; 2013 Jan; 119(1):226-32. PubMed ID: 22707281
[TBL] [Abstract][Full Text] [Related]
42. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach.
Parlak C; Mertsoylu H; Güler OC; Onal C; Topkan E
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):885-91. PubMed ID: 24495594
[TBL] [Abstract][Full Text] [Related]
43. Local Therapies Can Improve Intracerebral Control in Patients with Cerebral Metastasis from Gynecological Cancers.
Dziggel L; Janssen S; Bajrovic A; Veninga T; Trang NT; Khoa MT; Schild SE; Rades D
Anticancer Res; 2016 Sep; 36(9):4777-80. PubMed ID: 27630327
[TBL] [Abstract][Full Text] [Related]
44. A new tool predicting survival after radiosurgery alone for one or two cerebral metastases from lung cancer.
Rades D; Huttenlocher S; Dziggel L; Khoa MT; Van Thai P; Hornung D; Schild SE
Lung; 2015 Apr; 193(2):299-302. PubMed ID: 25528743
[TBL] [Abstract][Full Text] [Related]
45. Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients.
Rades D; Huttenlocher S; Khoa MT; Thai PV; Hornung D; Schild SE
Oncol Lett; 2015 Aug; 10(2):1109-1112. PubMed ID: 26622634
[TBL] [Abstract][Full Text] [Related]
46. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):3111-3114. PubMed ID: 29715148
[TBL] [Abstract][Full Text] [Related]
47. A new tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases.
Rades D; Huttenlocher S; Dziggel L; Blanck O; Hornung D; Mai KT; Ngo TT; Van Pham T; Schild S
Asian Pac J Cancer Prev; 2015; 16(7):2967-70. PubMed ID: 25854390
[TBL] [Abstract][Full Text] [Related]
48. Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer.
Dziggel L; Dahlke M; Janssen S; Hornung D; Blanck O; Khoa MT; Schild SE; Rades D
Anticancer Res; 2015 Dec; 35(12):6793-7. PubMed ID: 26637898
[TBL] [Abstract][Full Text] [Related]
49. A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer.
Rades D; Dziggel L; Janssen S; Blanck O; Hornung D; Schild SE
Anticancer Res; 2016 Mar; 36(3):1073-6. PubMed ID: 26977000
[TBL] [Abstract][Full Text] [Related]
50. The diagnosis and management of brain metastases.
van den Bent MJ
Curr Opin Neurol; 2001 Dec; 14(6):717-23. PubMed ID: 11723379
[TBL] [Abstract][Full Text] [Related]
51. Pre-Treatment Seizures in Patients With 1-3 Cerebral Metastases Receiving Local Therapies Plus Whole-brain Radiotherapy.
Witteler J; Kjaer TW; Tvilsted S; Schild SE; Rades D
In Vivo; 2020; 34(5):2727-2731. PubMed ID: 32871806
[TBL] [Abstract][Full Text] [Related]
52. Extra-cerebral Metastasis - An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT).
Rades D; Nguyen T; Schild SE
Anticancer Res; 2020 May; 40(5):2841-2845. PubMed ID: 32366432
[TBL] [Abstract][Full Text] [Related]
53. Stereotactic Radiosurgery Alone for One to Two Brain Metastases from Cancer of Unknown Primary.
Dziggel L; Bajrovic A; Schild SE; Rades D
Anticancer Res; 2018 Jan; 38(1):565-567. PubMed ID: 29277825
[TBL] [Abstract][Full Text] [Related]
54. A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone.
Huttenlocher S; Dziggel L; Hornung D; Blanck O; Schild SE; Rades D
Radiat Oncol; 2014 Sep; 9():215. PubMed ID: 25240823
[TBL] [Abstract][Full Text] [Related]
55. An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer.
Janssen S; Hansen HC; Schild SE; Rades D
Anticancer Res; 2018 Jun; 38(6):3753-3756. PubMed ID: 29848738
[TBL] [Abstract][Full Text] [Related]
56. Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery.
Ferrarese F; Baggio V; Zorat PL; Fiore D
Ann Oncol; 2006 Mar; 17 Suppl 2():ii71-72. PubMed ID: 16608990
[No Abstract] [Full Text] [Related]
57. Estimating survival of patients receiving radiosurgery alone for cerebral metastasis from melanoma.
Sehmisch L; Huttenlocher S; Schild SE; Rades D
J Dermatol; 2014 Oct; 41(10):918-21. PubMed ID: 25154301
[TBL] [Abstract][Full Text] [Related]
58. Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery?
Rades D; Schild SE
Strahlenther Onkol; 2012 Aug; 188(8):702-6. PubMed ID: 22418589
[TBL] [Abstract][Full Text] [Related]
59. Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
Hansen HC; Janssen S; Thieme C; Perlov A; Schild SE; Rades D
Anticancer Res; 2019 Mar; 39(3):1343-1346. PubMed ID: 30842167
[TBL] [Abstract][Full Text] [Related]
60. Treatment of brain metastases from hypernephroma.
Nieder C; Niewald M; Schnabel K
Urol Int; 1996; 57(1):17-20. PubMed ID: 8840485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
